Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.40
Delayed Data
As of Jun 15
 -0.03 / -0.87%
Today’s Change
3.00
Today|||52-Week Range
4.69
+3.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash632.3K374.5K2.0M851.0K
 
 
 
 
 
Short Term Investment Cash336.7K-257.8K1.6M-1.2M
 
 
 
 
 
Cash & Short Term Investments632.3K374.5K2.0M851.0K
 
 
 
 
 
 
ReceivablesReceivables675.2K278.6K9.7K87.0K
 
 
 
 
 
 
InventoriesInventories88.3K37.6K2.6K15.0K
 
 
 
 
 
 
Current AssetsPrepaid Expenses0.00685.00--1.0K
 
 
 
Other Current Assets----8.2K7.0K
 
 
 
Current Assets1.4M691.4K2.0M961.0K
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross552.2K536.6K538.4K539.0K
 
 
 
 
 
Depreciation-542.8K-533.2K-536.6K-538.0K
 
 
 
 
 
Other Assets0.0017.4K17.4K17.0K
 
 
 
 
Total Assets1.4M712.2K2.1M1.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.5M1.8M1.1M2.0M
 
 
 
 
 
Accrued Expenses379.3K201.4K14.3K0.00
 
 
 
 
Other Current Liabilities2.9M201.4K14.3K0.00
 
 
 
 
Other Liabilities4.5M2.3M1.4M2.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt1.3M1.2M1.3M0.00
 
 
 
 
Total Liabilities5.8M3.5M2.7M2.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.00--0.000.00--
Common Equity-4.8M-3.2M-641.4K-533.0K
 
 
 
 
 
Total Shareholder Equity-4.8M-3.2M-641.4K-533.0K
 
 
 
 
 
 
Share InformationCommon Shares Outstanding35.9M43.0M49.1M56.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.